[8 min read] Burden of skin cancer in Australia | Prof David Wilkinson

burden dw

For a really useful, powerful and insightful overview of the situation with skin cancer in Australia, I recommend a new article published in the MJA to “celebrate” National Skin Cancer Action Week. Continue reading “[8 min read] Burden of skin cancer in Australia | Prof David Wilkinson”

[WEBINAR] LED phototherapy in skin cancer, general dermatology and aesthetic medicine

LED

Do you use LED phototherapy in your practice, or do you wish to utilise its full potential in treating a range of skin concerns? In this webinar, Skin Cancer and Aesthetic Medicine Doctor Di King shares how light emitting diode (LED) can be used to treat a range of common dermatological presentations, including acne, superficial skin lesions, and wound healing. Continue reading “[WEBINAR] LED phototherapy in skin cancer, general dermatology and aesthetic medicine”

[2 min read] Does functional status predict survival in elderly keratinocyte carcinoma patients?

elderly patient functional status

How do you manage patients aged 85 and older with keratinocyte carcinoma? An assessment of a patient’s functional status may help to estimate which elderly patients will benefit from surgical treatment for keratinocyte carcinoma. However, predictive short-term survival in this population has not been determined. Continue reading “[2 min read] Does functional status predict survival in elderly keratinocyte carcinoma patients?”

[2 min read] Biopsy vs reflectance confocal microscopy in diagnosing BCC | Prof David Wilkinson

confocal

We all use biopsy to confirm the clinical diagnosis of basal cell carcinoma (BCC), to determine the sub-type of BCC, and hence to plan the formal treatment – this is usually by excision with appropriate margins, but of course we also consider other destructive methods or topical treatments.

Colleagues will be aware of the technology that is reflectance confocal microscopy (RCM). This is special imaging of the sub-structure of the skin, typically available in specialist centres, and can be used to identify BCC sub type, and to map margins. Continue reading “[2 min read] Biopsy vs reflectance confocal microscopy in diagnosing BCC | Prof David Wilkinson”

[2 min read] Surgery vs curettage & imiquimod for nodular BCC

nodular BCC

Nodular basal cell carcinoma (BCC) is most often treated with surgical excision. However, interest is increasing in minimally invasive treatments for these low-risk skin cancers. A new study reviewed the effectiveness of surgical excision compared with curettage and imiquimod cream in treating nodular BCC. Continue reading “[2 min read] Surgery vs curettage & imiquimod for nodular BCC”

[2 min read] Field treatments for actinic keratosis | Prof David Wilkinson

actinic keratosis

Treating actinic keratosis is very common in general practice, and especially so in primary care skin cancer medicine. Many patients require treatment of both individual lesions (for example, by cryotherapy) and of the whole field that is affected (for example, the whole face, using a topical treatment, or a field treatment more generally). Continue reading “[2 min read] Field treatments for actinic keratosis | Prof David Wilkinson”

[3 min read] Photodynamic therapy for Bowen’s disease

photodynamic

How effective and safe is photodynamic therapy in treating Bowen’s disease? Bowen’s disease is an intraepidermal squamous cell carcinoma (SCC). There are several alternatives for treatment of Bowen’s disease, including photodynamic therapy. A new study investigated the efficacy and safety of photodynamic therapy in treating the skin condition. Continue reading “[3 min read] Photodynamic therapy for Bowen’s disease”

[5 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [July 2020]

Giuseppe skin cancer update

In this month’s skin cancer update video, Professor Giuseppe Argenziano talks about the three possible outcomes that can be reached after you check a lesion: Excise, monitor, or do nothing. In most cases, lesions are either deemed suspicious and excised, or deemed safe and the patient goes home. Giuseppe warns that the other option – monitoring the lesion at follow-up appointments – should be used with caution and in limited cases. He goes through the scenarios in which monitoring the lesion is a good choice and how doctors can go about the follow-up procedure. Continue reading “[5 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [July 2020]”

[2 min read] Is psoriasis associated with increased risk of skin cancer?

Is psoriasis or psoriatic arthritis associated with an increased risk of cancer? A recent review looked at the association and risk of cancer in patients with these conditions. Continue reading “[2 min read] Is psoriasis associated with increased risk of skin cancer?”

[3 min read] 5 common treatments for non-melanoma skin cancer

treatments

Non-melanoma skin cancer is the most commonly diagnosed cancer in Australia, with around 800,000 confirmed cases each year. General practitioners alone have over one million skin cancer-related consultations annually, with lesion diagnosis being among patients’ most common skin concerns in primary care.

The two main types of non-melanoma skin cancer are: Continue reading “[3 min read] 5 common treatments for non-melanoma skin cancer”